17234346|t|Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
17234346|a|Alzheimer's disease (AD) is characterized by cognitive decline due to excess amyloid beta peptide (Abeta), neurofibrillary tangles, and neuronal loss. Abeta promotes neuronal apoptosis in AD by activating glycogen synthase kinase-3beta (GSK-3beta), leading to degradation of beta-catenin and inactivation of Wnt signaling. beta-Catenin interacts with the T-cell factor (TCF)/Lymphoid enhancer factor (LEF)-nuclear complex to mediate Wnt signaling and cell survival. Statins are associated with decreased prevalence of AD. Lovastatin has been shown to decrease the production of Abeta and to promote neuronal survival. The mechanisms of how statins promote neuronal survival are unclear. We propose that the neuroprotective effect of lovastatin may be due to inactivation of GSK-3beta activity, resulting in induction of Wnt signaling. Here, we report that lovastatin prevented Abeta-induced apoptosis in human SK-NSH cells. This was accompanied by reduction in active GSK-3beta, and increased nuclear translocation of beta-catenin, TCF-3, and LEF-1. Lovastatin treatment induced an increase in TCF/LEF-chloramphenicol acetyl transferase (CAT) gene reporter activity. More importantly, beta-catenin and TCF were required for the neuroprotective function of lovastatin. Our results suggest that lovastatin protects neuronal cells from Abeta-induced apoptosis and causes reduction in GSK-3beta activity, resulting in activation of Wnt signaling.
17234346	0	10	Lovastatin	Chemical	MESH:D008148
17234346	20	25	human	Species	9606
17234346	42	47	Abeta	Gene	351
17234346	56	64	toxicity	Disease	MESH:D064420
17234346	90	102	beta-catenin	Gene	1499
17234346	103	106	TCF	Gene	3172
17234346	122	141	Alzheimer's disease	Disease	MESH:D000544
17234346	143	145	AD	Disease	MESH:D000544
17234346	167	184	cognitive decline	Disease	MESH:D003072
17234346	221	226	Abeta	Gene	351
17234346	229	252	neurofibrillary tangles	Disease	MESH:D055956
17234346	258	271	neuronal loss	Disease	MESH:D009410
17234346	273	278	Abeta	Gene	351
17234346	310	312	AD	Disease	MESH:D000544
17234346	327	357	glycogen synthase kinase-3beta	Gene	2932
17234346	359	368	GSK-3beta	Gene	2932
17234346	397	409	beta-catenin	Gene	1499
17234346	445	457	beta-Catenin	Gene	1499
17234346	477	490	T-cell factor	Gene	3172
17234346	492	495	TCF	Gene	3172
17234346	640	642	AD	Disease	MESH:D000544
17234346	644	654	Lovastatin	Chemical	MESH:D008148
17234346	700	705	Abeta	Gene	351
17234346	855	865	lovastatin	Chemical	MESH:D008148
17234346	896	905	GSK-3beta	Gene	2932
17234346	978	988	lovastatin	Chemical	MESH:D008148
17234346	999	1004	Abeta	Gene	351
17234346	1026	1031	human	Species	9606
17234346	1032	1038	SK-NSH	CellLine	CVCL:0531
17234346	1090	1099	GSK-3beta	Gene	2932
17234346	1140	1152	beta-catenin	Gene	1499
17234346	1154	1159	TCF-3	Gene	6929
17234346	1165	1170	LEF-1	Gene	51176
17234346	1172	1182	Lovastatin	Chemical	MESH:D008148
17234346	1216	1219	TCF	Gene	3172
17234346	1260	1263	CAT	Chemical	-
17234346	1307	1319	beta-catenin	Gene	1499
17234346	1324	1327	TCF	Gene	3172
17234346	1378	1388	lovastatin	Chemical	MESH:D008148
17234346	1415	1425	lovastatin	Chemical	MESH:D008148
17234346	1455	1460	Abeta	Gene	351
17234346	1503	1512	GSK-3beta	Gene	2932
17234346	Association	MESH:D000544	1499
17234346	Association	MESH:D000544	351
17234346	Association	MESH:D000544	2932
17234346	Positive_Correlation	MESH:D008148	1499
17234346	Positive_Correlation	MESH:D008148	51176
17234346	Positive_Correlation	MESH:D008148	3172
17234346	Negative_Correlation	MESH:D008148	MESH:D000544
17234346	Negative_Correlation	MESH:D008148	2932
17234346	Negative_Correlation	MESH:D008148	351
17234346	Bind	1499	3172
17234346	Positive_Correlation	2932	351
17234346	Association	1499	2932
17234346	Positive_Correlation	MESH:D008148	6929
17234346	Association	MESH:D064420	351

